These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7742851)

  • 1. Intravesical oxybutynin in patients with posterior rhizotomies and sacral anterior root stimulators.
    Singh G; Thomas DG
    Neurourol Urodyn; 1995; 14(1):65-71. PubMed ID: 7742851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intermittent urethral catheterization and oxybutynin bladder instillation on urinary continence status and quality of life in a selected group of spinal cord injury patients with neuropathic bladder dysfunction.
    Vaidyananthan S; Soni BM; Brown E; Sett P; Krishnan KR; Bingley J; Markey S
    Spinal Cord; 1998 Jun; 36(6):409-14. PubMed ID: 9648197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of intravesical oxybutynin chloride in patients with detrusor hypertonicity and detrusor hyperreflexia.
    Kasabian NG; Vlachiotis JD; Lais A; Klumpp B; Kelly MD; Siroky MB; Bauer SB
    J Urol; 1994 Apr; 151(4):944-5. PubMed ID: 8126833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of detrusor hyperreflexia by the intravesical instillation of oxybutynine hydrochloride.
    Madersbacher H; Jilg G
    Paraplegia; 1991 Feb; 29(2):84-90. PubMed ID: 2023781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
    George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S
    ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravesical instillation of oxybutynin hydrochloride therapy for patients with a neuropathic bladder.
    Mizunaga M; Miyata M; Kaneko S; Yachiku S; Chiba K
    Paraplegia; 1994 Jan; 32(1):25-9. PubMed ID: 8015832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical oxybutynin for spinal cord injury patients.
    Szollar SM; Lee SM
    Spinal Cord; 1996 May; 34(5):284-7. PubMed ID: 8963976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of controlled-release oxybutynin on neurogenic bladder function in spinal cord injury.
    O'Leary M; Erickson JR; Smith CP; McDermott C; Horton J; Chancellor MB
    J Spinal Cord Med; 2003; 26(2):159-62. PubMed ID: 12828295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined intravesical and oral oxybutynin chloride in adult patients with spinal cord injury.
    Pannek J; Sommerfeld HJ; Bötel U; Senge T
    Urology; 2000 Mar; 55(3):358-62. PubMed ID: 10699610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    Amark P; Bussman G; Eksborg S
    Eur Urol; 1998 Aug; 34(2):148-53. PubMed ID: 9693251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxybutynin hydrochloride (3 mg) in the treatment of women with idiopathic detrusor instability.
    Moore KH; Hay DM; Imrie AE; Watson A; Goldstein M
    Br J Urol; 1990 Nov; 66(5):479-85. PubMed ID: 2249115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of intravesically instilled oxybutynin in refractory bladder hyperactivity. Study of 15 cases].
    Amarenco G; Adba MA; Kerdraon J
    Prog Urol; 1992; 2(4):660-3. PubMed ID: 1302108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic changes associated with behavioral and drug treatment of urge incontinence in older women.
    Goode PS; Burgio KL; Locher JL; Umlauf MG; Lloyd LK; Roth DL
    J Am Geriatr Soc; 2002 May; 50(5):808-16. PubMed ID: 12028165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interstitial cystitis: bladder training with intravesical oxybutynin.
    Barbalias GA; Liatsikos EN; Athanasopoulos A; Nikiforidis G
    J Urol; 2000 Jun; 163(6):1818-22. PubMed ID: 10799190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of intravesical oxybutynin chloride in children with neurogenic bladder.
    Greenfield SP; Fera M
    J Urol; 1991 Aug; 146(2 ( Pt 2)):532-4. PubMed ID: 1861294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.